These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 38706873)

  • 1. Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies.
    Armstrong M; Castellanos J; Christie D
    Front Pain Res (Lausanne); 2024; 5():1346053. PubMed ID: 38706873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.
    Kelly DF; Heinzerling K; Sharma A; Gowrinathan S; Sergi K; Mallari RJ
    Neurosurgery; 2023 Apr; 92(4):680-694. PubMed ID: 36512813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research.
    Bornemann J; Close JB; Spriggs MJ; Carhart-Harris R; Roseman L
    Front Psychiatry; 2021; 12():735427. PubMed ID: 34867525
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.
    Kelly JR; Gillan CM; Prenderville J; Kelly C; Harkin A; Clarke G; O'Keane V
    Front Psychiatry; 2021; 12():800072. PubMed ID: 34975593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.
    Zia FZ; Baumann MH; Belouin SJ; Dworkin RH; Ghauri MH; Hendricks PS; Henningfield JE; Lanier RK; Ross S; Berger A
    Neuropharmacology; 2023 Aug; 233():109528. PubMed ID: 37015315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
    Barnett BS; Greer GR
    J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What can neuroscience tell us about the potential of psychedelics in healthcare? How the neurophenomenology of psychedelics research could help us to flourish throughout our lives, as well as to enhance our dying.
    Mackenzie R
    Curr Drug Abuse Rev; 2014; 7(3):136-45. PubMed ID: 25563449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal Behavior in Psychedelic Research.
    Odland AU; Kristensen JL; Andreasen JT
    Pharmacol Rev; 2022 Oct; 74(4):1176-1205. PubMed ID: 36180111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development.
    Simonsson O; Stenfors CUD; Goldberg SB; Hendricks PS; Osika W
    Front Psychol; 2023; 14():1151626. PubMed ID: 37476092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy.
    Walsh Z; Thiessen MS
    Int Rev Psychiatry; 2018 Aug; 30(4):343-349. PubMed ID: 30251904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mindfulness meditation and psychedelics: potential synergies and commonalities.
    Holas P; Kamińska J
    Pharmacol Rep; 2023 Dec; 75(6):1398-1409. PubMed ID: 37926796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spiritual health practitioners' contributions to psychedelic assisted therapy: A qualitative analysis.
    Peacock C; Mascaro JS; Brauer E; Zarrabi AJ; Dunlop BW; Maples-Keller JL; Grant GH; Raison CL; Rab F; Palitsky R
    PLoS One; 2024; 19(1):e0296071. PubMed ID: 38166057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.
    Yaden DB; Earp D; Graziosi M; Friedman-Wheeler D; Luoma JB; Johnson MW
    Front Psychol; 2022; 13():873279. PubMed ID: 35677124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-blinding citizen science to explore psychedelic microdosing.
    Szigeti B; Kartner L; Blemings A; Rosas F; Feilding A; Nutt DJ; Carhart-Harris RL; Erritzoe D
    Elife; 2021 Mar; 10():. PubMed ID: 33648632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological Interventions for the Treatment of Chronic Pain in Adults.
    Driscoll MA; Edwards RR; Becker WC; Kaptchuk TJ; Kerns RD
    Psychol Sci Public Interest; 2021 Sep; 22(2):52-95. PubMed ID: 34541967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS; Dike CC
    Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia.
    Glynos NG; Pierce J; Davis AK; McAfee J; Boehnke KF
    J Psychoactive Drugs; 2023; 55(1):73-84. PubMed ID: 35001856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.
    Cavarra M; Mason NL; Kuypers KPC; Bonnelle V; Smith WJ; Feilding A; Kryskow P; Ramaekers JG
    Eur J Pain; 2024 Jan; 28(1):153-165. PubMed ID: 37599279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.